| 原料品名 | Deferoxamine mesylate |
|---|---|
| 原料中文名称 | 去铁铵 |
| 中文别名 | 甲磺酸去铁胺;去铁胺;去铁胺甲磺酸酯;去铁铵;甲磺酸去铁胺;甲磺酸去铁敏;甲磺酸除铁灵;DEFEROX胺甲磺酸盐;去铁铵;去铁敏 |
| 化学名称 | N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid |
| 分子式 | C26H52N6O11S |
| 分子量 | 656.79 |
| CAS号 | 138-14-7 |
| EINECS编号 | 暂无权限 |
| 结构式图片 | 暂无权限 |
| 美国DMF登记 | 暂无权限 |
供应商信息
| 企业名称 | NAVINTA LLC |
|---|---|
| 企业类型 | 生产商 |
| 地址 | 1499 Lower Ferry Road Ewing,Nj 08618 |
| 国家/地区 | 美国 |
| 公司官网 | 暂无权限 |
| 公司联系电话 | 暂无权限 |
| 公司邮箱 | 暂无权限 |
| 公司简介 | Navinta, LLC is a privately held generic pharmaceutical company, established in 2003, dedicated to the development and commercialization of pharmaceutical products to treat patients with chronic and life-threatening diseases. Navinta means “novelty” inspiring a culture of transforming ideas into technology and advancing innovation to the marketplace with new medicines. Navinta has focused its research and regulatory activities on developing new formulations, complex products, and unique pharmaceutical delivery systems. Navinta owns 21 process and product patents, 25 active Drug Master Files and has 12 approved ANDA commercial products. |
| 备注 | 若未能联系上供应商，可在药智通发布求购信息(https://a.d4t.cn/GbmkGL)，或联系药智通客服17318480790（微信同号） |
扩展信息
